Early molecular response in East African Philadelphia chromosome-positive chronic myeloid leukaemia patients treated with Imatinib and barriers to access treatment

BACKGROUND: Data about haematologic malignancies from Tanzania are sparse. African studies show that chronic myeloid leukaemia (CML) is the most common leukaemia, and registry data display a lower mean age at diagnosis. Prognosis is generally good with tyrosine kinase inhibitors, but the molecular r...

Descripción completa

Detalles Bibliográficos
Autores principales: Henke, Oliver, Mapendo, Priscus John, Mkwizu, Elifuraha Wilson, le Coutre, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498273/
https://www.ncbi.nlm.nih.gov/pubmed/33014131
http://dx.doi.org/10.3332/ecancer.2020.1089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498273/
https://www.ncbi.nlm.nih.gov/pubmed/33014131
http://dx.doi.org/10.3332/ecancer.2020.1089

Ejemplares similares